Celera abandons gene sequencing

Celera abandons gene sequencing The company that shared the glory for unravelling the code of life of human beings has turned its back on gene sequencing. Celera Genomics of Rockville, Maryland, announced this week that it is to develop drugs instead


Biotrends

Biotrends Two major reports highlight the globalization of biotechnology and the battle within the U.S. for regional supremacy


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog